A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the electrocardiogram (ECG) effects of fedovapagon
dose administration relative to placebo in healthy adult male and female subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Vantia Ltd
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination